China's CanSino Sees Delay In COVID Vaccine Rollout
But Single Shot, Storage Benefits?
Executive Summary
The Chinese company is enrolling an additional 10,000-20,000 people in its late-stage coronavirus vaccine study focusing on older and sicker patients.